NAUREX INC.

Profile

Company Names

NAUREX INC.

Addresses

1801 MAPLE AVENUE, SUITE 4300, EVANSTON, IL 60201

Phone Numbers

847-491-4802

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$155,014,736.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2014-11-21 
$79,999,999.00 
INDEFINITE 
INDEFINITE 
Equity 
4
2014-05-01 
$24,950,507.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2012-12-12 
$37,997,768.00 
$37,997,768.00 
$0.00 
Equity 
2
2011-05-09 
$10,959,862.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2009-06-24 
$1,106,600.00 
INDEFINITE 
INDEFINITE 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MITCHELL 
S. 
BLOOM 
EXECUTIVE OFFICER
AFFERENT PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  CORIDEA NC1, INC.   |  NAUREX INC.   |  RANA THERAPEUTICS, INC.   |  VOYAGER THERAPEUTICS, INC.   |  AXON THERAPIES INC.
RONALD 
M. 
BURCH 
EXECUTIVE OFFICER
NAUREX INC.
EDWARD 
 
CHANDLER 
DIRECTOR
NYMIRUM, INC.   |  SOLMENTUM, INC.   |  NAUREX INC.
EDWARD 
K. 
CHANDLER 
DIRECTOR
NAUREX INC.   |  TALK3, INC.   |  TEXTURA CORP
IAN 
 
FERRIER 
DIRECTOR
GOODMAN LTD   |  GOODMAN FUNDS MANAGEMENT LTD   |  NAUREX INC.   |  INNOVATIVE MED CONCEPTS, LLC
IAN 
R. 
FERRIER 
DIRECTOR
NAUREX INC.
WILBUR 
H. 
GANTZ 
DIRECTOR
NAUREX INC.   |  AEVI GENOMIC MEDICINE, INC.
BERT 
 
GETZ, JR. 
DIRECTOR
NAUREX INC.
EDWARD 
 
GETZ, JR. 
DIRECTOR
NAUREX INC.
JASWANT 
 
GIDDA 
EXECUTIVE OFFICER
NAUREX INC.   |  ANAGIN, INC.
TERRY 
 
GOULD 
DIRECTOR
NEURALTUS PHARMACEUTICALS, INC.   |  PROTEUS BIOMEDICAL INC   |  LIGHT SCIENCES ONCOLOGY INC   |  INCLINE THERAPEUTICS, INC.   |  NAUREX INC.   |  ONCOMED PHARMACEUTICALS INC   |  OUTPOST MEDICINE, LLC   |  ATOX BIO INC.   |  QPEX BIOPHARMA, INC.   |  ICOSAVAX, INC.
TERRY 
P. 
GOULD 
DIRECTOR
NAUREX INC.   |  APTINYX INC.
ROBERT 
J. 
HOMBACH 
DIRECTOR
NAUREX INC.   |  EDGE SURGICAL, INC.   |  CARMAX INC
AMIN 
 
KHAN 
EXECUTIVE OFFICER
TRINITY BIOSYSTEMS INC   |  NAUREX INC.
AMIN 
C. 
KHAN 
EXECUTIVE OFFICER
NAUREX INC.
MOHAMED 
AMIN 
KHAN 
EXECUTIVE OFFICER
NAUREX INC.
ASHISH 
 
KHANNA 
EXECUTIVE OFFICER
NAUREX INC.   |  SUTROVAX, INC.   |  APTINYX INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  FOUNTAIN THERAPEUTICS, INC.
J. DAVID 
 
LEANDER 
EXECUTIVE OFFICER
NAUREX INC.
JAN 
E. 
LEETSMA 
DIRECTOR
NAUREX INC.
JOSEPH 
R. 
MOSKAL 
EXECUTIVE OFFICER, DIRECTOR
NAUREX INC.   |  APTINYX INC.
NORBERT 
 
RIEDEL 
EXECUTIVE OFFICER, DIRECTOR
NAUREX INC.   |  TRACT THERAPEUTICS, INC.   |  ALCYONE THERAPEUTICS, INC.   |  ATSENA THERAPEUTICS, INC.   |  NEELA THERAPEUTICS, INC.
NORBERT 
C. 
RIEDEL 
DIRECTOR
NAUREX INC.
NORBERT 
G. 
RIEDEL 
EXECUTIVE OFFICER, DIRECTOR
NAUREX INC.   |  APTINYX INC.
JAMES 
 
SCHULZ 
EXECUTIVE OFFICER
NAUREX INC.   |  COFERON, INC.   |  ANAGIN, INC.   |  SCIOTO BIOSCIENCES, INC.   |  FIRST STATE HOLDING CO.
DEREK 
 
SMALL 
EXECUTIVE OFFICER, DIRECTOR
NAUREX INC.   |  COFERON, INC.   |  ANAGIN, INC.   |  GATE NEUROSCIENCES, INC.
DEREK 
A. 
SMALL 
DIRECTOR
NAUREX INC.
J.S. "STARK" 
 
THOMPSON 
DIRECTOR
NAUREX INC.
DAVID 
C. 
U-PRICHARD 
DIRECTOR
NAUREX INC.   |  LIFE TECHNOLOGIES CORP
KENNETH 
J. 
WIDDER 
DIRECTOR
EVOKE PHARMA INC   |  NAUREX INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-12-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-21 
2014-05-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-01 
2012-12-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-12 
2011-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-09 
2011-02-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-24 
2010-03-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-24 
2009-07-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#